Ipek Gozler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ipek Gozler has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Berranur Sert
Molecular Biology, Institute of Science and Technology, Üsküdar University
1 shared publication Burcu TürKgenç
1 shared publication- Busra Tekirdagli
Transgenic Cell Technologies and Epigenetic Application and Research Center (TRGENMER), Üsküdar University, Istanbul, Turkey
1 shared publication - Cihan Tastan
Üsküdar Üniversitesi
1 shared publication - Ebru Cam
Transgenic Cell Technologies and Epigenetic Application and Research Center (TRGENMER), Üsküdar University, Istanbul, Turkey
1 shared publication - Fatmanur Erkek
Transgenic Cell Technologies and Epigenetic Application and Research Center (TRGENMER), Üsküdar University, Istanbul, Turkey
1 shared publication
Latest Publications
- Open Access
- 9 June 2026
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 58 (4) , 1-5
Investigation of CLOCK rs1801260 Polymorphism of Circadian Genes in Schizophrenia Patients
Background: Schizophrenia is a mental condition characterized by abnormalities in emotional reactivity, thought processes, and perception. Recent studies have suggested a possible connection between the pathophysiology of schizophrenia and the CLOCK gene, a key element of the biological circadian rhythm. The CLOCK rs1801260 polymorphism has not yet been studied in a Turkish population with schizophrenia, and the existing data are contradictory. This study aimed to compare and interpret the CLOCK rs1801260 polymorphism in terms of demographic characteristics, genotype, and allele distribution in patients with schizophrenia and healthy controls. Methods: Deoxyribonucleic acid was purified from peripheral blood samples of 50 schizophrenia patients and 50 healthy control subjects, matched for age and sex. Genotyping was conducted by real-time polymerase chain reaction using the TaqMan Kit. Results: The odds of having the risk-associated TC or CC genotypes vs. the TT genotype were significantly higher in patients with schizophrenia compared to healthy controls (odds ratio (OR) = 2.92), and the risk C allele was also twice as prevalent in schizophrenia patients (OR = 2.00). The distributions of CLOCK rs1801260 genotypes (TT, TC, and CC) in the schizophrenia and the healthy control groups were independent of age and sex. Conclusion: The presence of the TC or CC genotypes, or having the homozygous or heterozygous C allele, may pose a risk for schizophrenia in the Turkish population. If confirmed in larger and more diverse samples, the CLOCK rs1801260 polymorphism may serve as a genetic marker for identifying at-risk individuals and guiding individualized treatment strategies aimed at stabilizing circadian rhythm. Cite this article as: Yekayeva P, Türkgenç B, Gözler T, Yüksel I, Ulucan K, Tarhan N. Investigation of CLOCK rs1801260 polymorphism of circadian genes in schizophrenia patients. Eurasian J Med. 2026, 58(4), 1049, doi: 10.5152/eurasianjmed.2026.251049.
- 9 June 2026
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 58 (4) , 1-5
Open AccessInvestigation of CLOCK rs1801260 Polymorphism of Circadian Genes in Schizophrenia Patients
Background: Schizophrenia is a mental condition characterized by abnormalities in emotional reactivity, thought processes, and perception. Recent studies have suggested a possible connection between the pathophysiology of schizophrenia and the CLOCK gene, a key element of the biological circadian rhythm. The CLOCK rs1801260 polymorphism has not yet been studied in a Turkish population with schizophrenia, and the existing data are contradictory. This study aimed to compare and interpret the CLOCK rs1801260 polymorphism in terms of demographic characteristics, genotype, and allele distribution in patients with schizophrenia and healthy controls. Methods: Deoxyribonucleic acid was purified from peripheral blood samples of 50 schizophrenia patients and 50 healthy control subjects, matched for age and sex. Genotyping was conducted by real-time polymerase chain reaction using the TaqMan Kit. Results: The odds of having the risk-associated TC or CC genotypes vs. the TT genotype were significantly higher in patients with schizophrenia compared to healthy controls (odds ratio (OR) = 2.92), and the risk C allele was also twice as prevalent in schizophrenia patients (OR = 2.00). The distributions of CLOCK rs1801260 genotypes (TT, TC, and CC) in the schizophrenia and the healthy control groups were independent of age and sex. Conclusion: The presence of the TC or CC genotypes, or having the homozygous or heterozygous C allele, may pose a risk for schizophrenia in the Turkish population. If confirmed in larger and more diverse samples, the CLOCK rs1801260 polymorphism may serve as a genetic marker for identifying at-risk individuals and guiding individualized treatment strategies aimed at stabilizing circadian rhythm. Cite this article as: Yekayeva P, Türkgenç B, Gözler T, Yüksel I, Ulucan K, Tarhan N. Investigation of CLOCK rs1801260 polymorphism of circadian genes in schizophrenia patients. Eurasian J Med. 2026, 58(4), 1049, doi: 10.5152/eurasianjmed.2026.251049.
- Open Access
Assessing Immune Stability in Space: Haematological and T Cell Profiling of Astronauts During the MESSAGE Science Mission in Axiom-3 on the ISS
Microgravity presents unique challenges to human physiology, particularly the immune system, during spaceflight. T lymphocytes, key components of adaptive immunity, play a vital role in immune regulation, yet the effects of microgravity on T-cell function and gene expression remain incompletely understood. This study, conducted as part of the MESSAGE (Microgravity Associated Genetics) Science Mission in the Axiom-3 mission ( https://www.nasa.gov/mission/station/research-explorer/investigation/?#id=9100 ). We aimed to investigate how microgravity influences immune cell responses by analysing blood samples from three astronauts between pre-flight and during their space mission on the ISS (post-launch Day 4, Day 7, and Day 10 in ISS). Hemogram analysis revealed no statistically significant differences in leukocyte, erythrocyte, haemoglobin, and haematocrit levels between pre-flight and in-flight samples, suggesting a stable haematological profile under microgravity conditions. T cell subpopulation analysis indicated fluctuations in effector memory T cells (TemEARLY and TemLATE), but these changes did not reach statistical significance. These findings suggest that, within the short duration of spaceflight, haematological and immune parameters remain largely stable, underscoring the need for further research into long-term immune adaptations in microgravity. As a next step, transcriptomic analysis will be performed to identify microgravity-associated gene candidates, and CRISPR-based knock-out of the genes in T cells will be generated to explore their functional roles in microgravity-induced immune modulation.
Open AccessAssessing Immune Stability in Space: Haematological and T Cell Profiling of Astronauts During the MESSAGE Science Mission in Axiom-3 on the ISS
Microgravity presents unique challenges to human physiology, particularly the immune system, during spaceflight. T lymphocytes, key components of adaptive immunity, play a vital role in immune regulation, yet the effects of microgravity on T-cell function and gene expression remain incompletely understood. This study, conducted as part of the MESSAGE (Microgravity Associated Genetics) Science Mission in the Axiom-3 mission ( https://www.nasa.gov/mission/station/research-explorer/investigation/?#id=9100 ). We aimed to investigate how microgravity influences immune cell responses by analysing blood samples from three astronauts between pre-flight and during their space mission on the ISS (post-launch Day 4, Day 7, and Day 10 in ISS). Hemogram analysis revealed no statistically significant differences in leukocyte, erythrocyte, haemoglobin, and haematocrit levels between pre-flight and in-flight samples, suggesting a stable haematological profile under microgravity conditions. T cell subpopulation analysis indicated fluctuations in effector memory T cells (TemEARLY and TemLATE), but these changes did not reach statistical significance. These findings suggest that, within the short duration of spaceflight, haematological and immune parameters remain largely stable, underscoring the need for further research into long-term immune adaptations in microgravity. As a next step, transcriptomic analysis will be performed to identify microgravity-associated gene candidates, and CRISPR-based knock-out of the genes in T cells will be generated to explore their functional roles in microgravity-induced immune modulation.
- 2 May 2024
- Published by Nobel Tip Kitabevleri
- p. 81-84
The Situation in Our Country in Breastfeeding
- 2 May 2024
- Published by Nobel Tip Kitabevleri
- p. 23-25
Protecting and Supporting Breastfeeding
- 14 March 2023
- Published by Nobel Tip Kitabevleri
- p. 31-40
Laboratory, Imaging Methods and Biopsy